Teaching Machines to See in 3D: The Chiral Blind Spot in AI-Driven Drug Discovery
Can an AI truly understand a molecule if it cannot tell left from right? Artificial intelligence now shapes the earliest and most consequential stages of drug discovery, from virtual screening and ADMET prediction to generative molecular design. Yet many of these systems operate in an effectively achiral digital environment, where molecules are represented as flat graphs, strings, or feature vectors that often erase or blur stereochemical information. This article introduces the concept of chiral bias …
Teaching Machines to See in 3D: The Chiral Blind Spot in AI-Driven Drug Discovery Read More »









